Results 121 to 130 of about 5,052,415 (279)

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; March 2023

open access: yes
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Nabiha H. Saifee   +24 more
wiley   +1 more source

Association of Three HIF‐1α Genotypes With Susceptibility and Severity of Chronic Kidney Disease

open access: yesClinical and Translational Science, Volume 19, Issue 10, October 2026.
ABSTRACT Hypoxic signaling is a critical factor in the pathogenesis of Chronic Kidney Disease (CKD). Hypoxia‐Inducible Factor 1 (HIF‐1) is a transcription factor that is highly expressed in the kidney and is associated with renal tubular hypoxic adaptation. Variation in the HIF‐1α subunit gene has been associated with renal pathologies.
Hanifa Aktar   +3 more
wiley   +1 more source

The Bloodline newsletter : Sickle Cell Data Collection (SCDC) Program quarterly newsletter ; July 2023

open access: yes
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)

core  

Pharmacotherapy of sickle cell anemia

open access: yes, 2018
The pharmacology of sickle cell anaemia entails the study and of the cellular basis of most of the drugs used to manage this condition.Its pharmacodynamic and pharmacokinetics properties and the future treatment of sickle cell diseaseLBáltalános ...
Palomeras, Yemisi
core  

Real‐World Claims Data on Prescribed Drugs and the Associated Drug–Drug Interaction Risk in Sickle Cell Disease in the United States

open access: yesClinical and Translational Science, Volume 19, Issue 10, October 2026.
Real‐world prescription data from 6230 adolescents and adults living with sickle cell disease (SCD) were combined with a drug–drug interaction (DDI) database to characterize the population‐level DDI risk. The findings support a DDI risk assessment for development of novel SCD therapies and during clinical management of SCD.ABSTRACTSickle cell disease ...
Rune Aabjerg Nørgaard   +4 more
wiley   +1 more source

Three Tips for Safe Use of Medicines for People with Sickle Cell Disease

open access: yes
People with sickle cell disease (SCD) are often prescribed medicines for common complications of SCD.CS 319852-APublication date from document properties.sickle-cell-3-tips-safe-med-use-h ...

core  

Is There a Difference in Occurrence of Complications Between Adults With Hemoglobin SS and Hemoglobin SC Disease: An Extended Systematic Review

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 824-837, October 2026.
ABSTRACT Sickle cell disease (SCD) is characterized by both acute and chronic complications. The clinical manifestation of these complications differs between genotypes. Given the large amount of research already published, this systematic review aims to offer a complete overview of types of sickle cell complications between adults in the most common ...
Martijn van der Meer   +3 more
wiley   +1 more source

Steps to Better Kidney Health for People with Sickle Cell Disease [PDF]

open access: yes
People with sickle cell disease (SCD) are at greater risk than the general population for kidney complications. Share your medical history with your healthcare team so it can properly identify and treat any complications of SCD you currently have or may ...

core  

What makes a lonely child: environmental, health, and multimodal neuroimaging correlates of prospective loneliness in the ABCD study

open access: yesJournal of Child Psychology and Psychiatry, Volume 67, Issue 10, Page 1714-1728, October 2026.
Background Loneliness in childhood is a growing public health concern, yet early multilevel candidate risk and protective factors remain insufficiently mapped. Systematic investigation is essential to guide prevention and intervention during sensitive developmental periods.
Ting Yat Wong   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy